.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Cerilliant
Citi
Merck
Cipla
Federal Trade Commission
Cantor Fitzgerald
Chinese Patent Office
McKesson

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: ➤ Sign Up

« Back to Dashboard

Details for Patent: ➤ Sign Up

Title:Ultrasound contrast agents and methods of making and using them
Abstract: Gas or air filled microbubble suspensions in aqueous phases usable as imaging contrast agents in ultrasonic echography. They contain laminarized surfactants and, optionally, hydrophilic stabilizers. The laminarized surfactants can be in the form of liposomes. The suspensions are obtained by exposing the laminarized surfactants to air or a gas before or after admixing with an aqueous phase. One can impart outstanding resistance against collapse under pressure to these gas-filled microbubbles used as contrast agents in ultrasonic echography by using as fillers gases whose solubility in water, expressed in liter of gas by liter of water under standard conditions, divided by the square root of the molecular weight does not exceed 0.003.
Inventor(s): Schneider; Michel (Troinex, CH), Yan; Feng (Carouge, CH), Gercel, legal representative; Nadine (Ambilly, FR), Puginier; Jerome (La Chable-Beaumont, FR), Barrau; Maria-Bernadette (Geneve, CH), Bussat; Philippe (Falgeres, FR), Hybl; Eva (Heidelberg, DE), Bichon; Daniel (Montpeiller, FR), Grenier, deceased; Pascal (Ambilly, FR)
Assignee: Bracco International B.V. (Amsterdam, NL)
Filing Date:Apr 12, 2002
Application Number:10/120,390
Claims:1. A method of ultrasound imaging comprising: administering to a subject a contrast agent comprising microbubbles, said microbubbles comprising C.sub.2ClF.sub.5 gas and said microbubbles being stabilized at least in part by a mono molecular membrane layer of cardiolipin; and ultrasonically imaging said subject.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Accenture
Novartis
UBS
Teva
Express Scripts
McKesson
Fuji
Argus Health
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot